US WorldMeds, LLC. and Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health Companies Inc. announced the U.S. launch and availability of Lucemyra (lofexidine) 0.18 mg tablets, the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. The Centers for Disease Control and Prevention estimates that…